AllianceBernstein Holding (NYSE:AB) reported quarterly earnings of $0.71 per share which met the analyst consensus estimate. This is a 21.98 percent decrease over earnings of $0.91 per share from the same period last year.
Oramed Granted NASH Patent In Europe
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that the European Patent Office has granted the Company